Mankind Pharma: Revenue Growth but Margins under Pressure
Moneylife Digital Team 08 December 2025
Mankind Pharma Limited (Mankind) delivered robust top-line expansion in Q2FY25-26, posting revenues of ₹3,697 crore and marking a 20.8% year-on-year (y-o-y) increase. The growth was driven by...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback